• RNA Polymerase II Degradation Drives Oocyte Chromatin Reorga

  2026-07-02

  This study uncovers RNA polymerase II degradation as the central mechanism triggering chromatin reorganization in mammalian oocyte maturation. By reconstituting the nonsurrounded to surrounded nucleolus (NSN-to-SN) transition, the authors challenge prevailing epigenetic models and offer a new framework for understanding developmental competence in oocytes.

• Differential SHH and FGF10 Expression Drives Urethral Develo

  2026-07-02

  This study systematically compares penile urethra and prepuce formation in mice and guinea pigs, revealing that differences in Sonic Hedgehog (Shh), Fgf10, and Fgfr2 expression underlie distinct developmental mechanisms. The findings deepen our understanding of mammalian genital morphogenesis and provide a new foundation for congenital malformation research.

• X-Gal for Blue-White Screening: Precision in Molecular Cloni

  2026-07-01

  X-Gal (5-bromo-4-chloro-indolyl-β-D-galactopyranoside) empowers rapid, visually decisive blue-white colony screening and β-galactosidase assays in molecular cloning. Discover how APExBIO’s high-purity X-Gal delivers unparalleled clarity, reproducibility, and workflow optimization—even for advanced recombinant DNA applications.

• Native Protein Extraction: Redefining Translational Oncology

  2026-07-01

  This article explores how mechanistic insight into cancer-associated fibroblast (CAF)-mediated chemoresistance in prostate cancer, via the ANGPTL4-IQGAP1 axis, drives the need for rigorous, non-denaturing protein extraction. It argues that APExBIO’s Cell lysis buffer for WB and IP is essential for preserving native protein interactions, ensuring translational fidelity, and elevating sample integrity across animal and plant model systems. By connecting breakthrough biological discoveries to workflow best practices, this piece offers strategic guidance for translational researchers navigating the tumor microenvironment.

• Antibody Targeting of SCUBE3 Suppresses Oncogenic Signaling

  2026-06-30

  This study identifies secretory SCUBE3 as a central driver of cancer progression, therapy resistance, and immune evasion. By developing and deploying a first-in-class neutralizing antibody against SCUBE3, the research demonstrates both suppression of oncogenic signaling and restoration of antitumor immunity, highlighting a promising target for pan-cancer therapy.

• Smoothened Function in Honeybee Olfaction: Insights from Smo

  2026-06-30

  Guo et al. (2024) provide the first functional and expression analysis of the Smoothened (Smo) protein in Apis mellifera, establishing its pivotal role in regulating olfactory receptor expression and behavior. Their findings demonstrate that pharmacological Smo modulation—including via Purmorphamine—directly influences sensory processing, offering a molecular entry point for insect sensory biology and translational Hedgehog pathway research.

• Cabazitaxel (XRP6258) for Taxane-Resistant Tumor Models

  2026-06-29

  Cabazitaxel addresses taxane resistance in cancer research models, particularly where P-glycoprotein expression limits the effectiveness of classic taxanes. It is optimized for DMSO- or ethanol-based assays but should not be used in water-based systems or for long-term solution storage.

• Hematoxylin and Eosin Staining Kit: Practical Workflow Guide

  2026-06-29

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) offers ready-to-use solutions for reliable visualization of tissue and cellular morphology in research settings. It addresses common bottlenecks in histopathological and cytological staining by simplifying preparation and standardizing results. This kit is not intended for diagnostic or clinical decision-making.

• Bovine Insulin in Cell Culture: Protocols, Uses, and Optimiz

  2026-06-28

  Bovine insulin from APExBIO stands out as a high-purity, reliable growth factor supplement for cultured cells, powering advanced research in proliferation and metabolism. This guide translates bench-top evidence and reference breakthroughs into actionable protocols, troubleshooting strategies, and future-focused insights for metabolic and regenerative workflows.

• One-step TUNEL Cy3 Apoptosis Detection Kit: Precision TdT La

  2026-06-27

  The One-step TUNEL Cy3 Apoptosis Detection Kit streamlines apoptosis detection in tissue sections and cultured cells, leveraging sensitive TdT-mediated Cy3 labeling for direct, quantitative analysis. Its protocol flexibility, compatibility across sample types, and robust fluorescent signal make it an indispensable tool for high-confidence apoptosis research and workflow optimization.

• Recent Synthetic Advances in Ibuprofen and Naproxen: Technic

  2026-06-26

  This review synthesizes the latest advances in the asymmetric and practical synthesis of ibuprofen and naproxen, as outlined by Ha and Paek. It highlights how evolving chemical methodologies and continuous-flow strategies are enabling more efficient, scalable, and selective production routes—key for facilitating advanced inflammation pathway research and enabling the development of more potent nonsteroidal anti-inflammatory drug derivatives.

• Pol II Degradation Triggers Cell Death Beyond Transcription

  2026-06-26

  This study uncovers a transcription-independent cell death pathway activated by targeted degradation of RNA polymerase II (Pol II). The findings reshape our understanding of the connection between transcriptional machinery and apoptosis, with implications for non-Hodgkin lymphoma and acute myelogenous leukemia research.

• Phosbind Acrylamide: Streamlining SDS-PAGE Phosphorylation D

  2026-06-25

  Phos binding reagent (Phosbind) acrylamide redefines protein phosphorylation analysis by enabling precise, antibody-free SDS-PAGE detection of phosphoproteins. This phosphate-binding reagent from APExBIO accelerates workflows for signaling pathway research and troubleshooting kinase assays, offering unmatched clarity and reproducibility.

• Clodronate Liposomes: Applied Workflows for In Vivo Macropha

  2026-06-25

  Unlock precision immune cell modulation with Clodronate Liposomes—engineered for robust, tissue-specific macrophage depletion in complex in vivo models. This guide details actionable protocols, advanced troubleshooting, and novel insights from single-cell research, empowering translational studies in immunology and tissue injury.

• LMP2A-mTORC1-GCNT3 Axis Regulates NPC Progression via EMT an

  2026-06-24

  This study elucidates how Epstein-Barr virus-encoded LMP2A enhances GCNT3 expression in nasopharyngeal carcinoma (NPC) cells through mTORC1 activation. The identification of a positive feedback loop between mTORC1 and GCNT3, driving EMT and proliferation, suggests new molecular targets for NPC research and therapy.

16257 records 1/1084 page Next 12345 下5页 Last page